164 related articles for article (PubMed ID: 4342010)
1. Classical maple syrup urine disease: cofactor resistance.
Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
[No Abstract] [Full Text] [Related]
2. Enzyme activity in classical and variant forms of maple syrup urine disease.
Dancis J; Hutzler J; Snyderman SE; Cox RP
J Pediatr; 1972 Aug; 81(2):312-20. PubMed ID: 5042489
[No Abstract] [Full Text] [Related]
3. [Studies on "branched chain oxoacid aciduria" (maple syrup diseases)].
Goedde HW; Blume KG; Möhlenbeck F; Rotthauwe HW; Simon HA; Lang K
Med Klin; 1966 Dec; 61(52):2063-7. PubMed ID: 4385693
[No Abstract] [Full Text] [Related]
4. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
[No Abstract] [Full Text] [Related]
5. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
Wendel U; Wentrup H; Rüdiger HW
Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
[TBL] [Abstract][Full Text] [Related]
6. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE].
SILBERMANSCHWARTZMAN J
An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039
[No Abstract] [Full Text] [Related]
7. The role of thiamin in maple syrup urine disease.
Elsas LJ; Danner DJ
Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
[No Abstract] [Full Text] [Related]
8. Maple syrup urine disease metabolites studies in cerebellum cultures.
Silberberg DH
J Neurochem; 1969 Jul; 16(7):1141-6. PubMed ID: 5816072
[No Abstract] [Full Text] [Related]
9. Metabolism of [1-(14)C] and [2-(14)C] leucine in cultured skin fibroblasts from patients with isovaleric acidemia. Characterization of metabolic defects.
Tanaka K; Mandell R; Shih VE
J Clin Invest; 1976 Jul; 58(1):164-72. PubMed ID: 932204
[TBL] [Abstract][Full Text] [Related]
10. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
Fischer MH; Gerritsen T
Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
[No Abstract] [Full Text] [Related]
11. [Biochemical-genetic studies in maple syrup disease].
Goedde HW; Blume KG
Med Welt; 1968 Dec; 49():2699-703. PubMed ID: 5730703
[No Abstract] [Full Text] [Related]
12. M aple syrup urine disease. A review with a report of an additional case.
Schwartz JF; Kolendrianos ET
Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
[No Abstract] [Full Text] [Related]
13. Heterogeneity in maple syrup urine disease: aspects of cofactor requirement and complementation in cultured fibroblasts.
Singh S; Willers I; Goedde HW
Clin Genet; 1977 Apr; 11(4):277-84. PubMed ID: 192504
[TBL] [Abstract][Full Text] [Related]
14. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
Skaper SD; Molden DP; Seegmiller JE
Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
[TBL] [Abstract][Full Text] [Related]
15. Analysis of maple syrup urine disease in cell culture: use of substrates.
Schadewaldt P; Beck K; Wendel U
Clin Chim Acta; 1989 Sep; 184(1):47-56. PubMed ID: 2598467
[TBL] [Abstract][Full Text] [Related]
16. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
Irwin WC; Martel SB; Goluboff N
Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
[No Abstract] [Full Text] [Related]
17. Transaminations between amino acids and keto acids elevated in phenylketonuria and maple syrup urine disease.
Lees GJ; Weiner N
J Neurochem; 1973 Feb; 20(2):389-403. PubMed ID: 4698286
[No Abstract] [Full Text] [Related]
18. Maple syrup urine disease: coenzyme function and prenatal monitoring.
Elsas LJ; Priest JH; Wheeler FB; Danner DJ; Pask BA
Metabolism; 1974 Jun; 23(6):569-79. PubMed ID: 4857216
[No Abstract] [Full Text] [Related]
19. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
[No Abstract] [Full Text] [Related]
20. On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease.
Schadewaldt P; Hammen HW; Dalle-Feste C; Wendel U
J Inherit Metab Dis; 1990; 13(2):137-50. PubMed ID: 2116545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
